CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 82.67% of retail investor accounts lose money when trading CFDs. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money

Veeva share price nosedives despite Q2 proft

By Monte Stewart


Updated

Veeva
Veeva Photo: Shutterstock

Veeva’s shares plummeted in after-hours trading on Wednesday, 1 September – even though the life sciences industry cloud-computing provider’s profit increased 38.29% in the latest fiscal quarter.

The share price was down 8.54%, or $28.52, at $305.8.82 in New York after closing up a modest 0.55%, or $1.84, as the bell sounded.

The share decline coincided with the release of the company’s latest earnings report after markets closed. Pleasanton Calif.-based Veeva boosted its net income to $124.6m from $90.1m a year earlier.

“It was another strong quarter with results ahead of guidance and continued strength across the business,” said Veeva founder and CEO Peter Gassner in a conference call with analysts.

Revenue rises 29%

The company’s revenue rose 29% to $455.6m from $353.7m.

“From a macro perspective, the life sciences industry is doing well,” said Gassner during the earnings call. “Innovations in medical science and an industry-wide move to digital are creating healthy demand for our offerings that we expect to continue for the foreseeable future.”

According to Zacks Equity Research, the company’s second-quarter 2022 adjusted per-share earnings of $0.94 surpassed analysts’ expectation of $0.86 per share. The revenue increase slightly exceeded the $452m expected among analysts polled by FactSet.

For accounting purposes, the period ending 31 July was Veeva’s second quarter of 2022.

What is your sentiment on BTC/USD?

89740.70
Bullish
or
Bearish
Vote to see Traders sentiment!

Gold

2,573.27 Price
-0.980% 1D Chg, %
Long position overnight fee -0.0176%
Short position overnight fee 0.0094%
Overnight fee time 22:00 (UTC)
Spread 0.60

XRP/USD

0.69 Price
-5.110% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 22:00 (UTC)
Spread 0.01168

ETH/USD

3,188.11 Price
-2.860% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 22:00 (UTC)
Spread 6.00

BTC/USD

89,740.70 Price
+1.530% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 22:00 (UTC)
Spread 106.00

Most employees get 5% pay boost

Gassner said the company is dealing with labour pressures amid increasing demand for talent across the life sciences industry. Starting Wednesday, the company is giving most employees a 5% salary increase.

But the pay boost does not apply to the company’s leadership team and employees earning more than $300,000 per year.

CFO Brent Bowman said on the earnings call that the company anticipates calculated billings of $315m in the third quarter of 2022 and $1.94bn for all of fiscal-year 2022. If achieved, the full-year level would mark a 21% year-over-year increase.

In the second quarter of fiscal-year 2022, calculated billings were $11m above the company’s guidance and up 33% year-over-year.

In the third quarter of fiscal-year 2022, Veeva expects to generate $464m to $466m in revenue. The company’s financial outlook calls for full fiscal-year 2022 revenue of $1.83bn to $1.835bn.

Trade Veeva Systems - VEEV CFD

 

1m
5m
15m
30m
1H
4H
1D
1W

Rate this article

Capital Com is an execution-only service provider. The material provided in this article is for information purposes only and should not be understood as investment advice. Any opinion that may be provided on this page does not constitute a recommendation by Capital Com or its agents and has not been prepared in accordance with the legal requirements designed to promote investment research independence. While the information in this communication, or on which this communication is based, has been obtained from sources that Capital.com believes to be reliable and accurate, it has not undergone independent verification. No representation or warranty, whether expressed or implied, is made as to the accuracy or completeness of any information obtained from third parties. If you rely on the information on this page, then you do so entirely at your own risk.

Still looking for a broker you can trust?

Join the 660,000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading